Patient-Delivered Partner Treatment for Male Urethritis: A Randomized, Controlled Trial
Open Access
- 1 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (5) , 623-629
- https://doi.org/10.1086/432476
Abstract
Background. Traditional partner referral for sexually transmitted diseases (STDs) is ineffective at assuring that partners are treated. Alternative methods are needed. We sought to determine whether patient-delivered partner treatment (PDPT) is better than 2 different methods of partner referral in providing antibiotic treatment to sex partners of men with urethritis and in reducing recurrence of Chlamydia trachomatis and Neisseria gonorrhoeae. Methods. Men who received a diagnosis of urethritis at a public STD clinic in New Orleans, Louisiana, during the period of December 2001 through March 2004 were randomly assigned according to the month of treatment for either standard partner referral (PR), booklet-enhanced partner referral (BEPR), or PDPT. At baseline and after 1 month, men were asked to provide information about each partner and were tested for C. trachomatis and N. gonorrhoeae. Results. Most enrolled index men (n = 977) were >24 years of age (51.6%) and African American (95%) and had ⩾2 partners (68.3%). They reported information on 1991 partners, and 78.8% were reinterviewed 4–8 weeks later. Men in the PDPT arm were more likely than men in the BEPR and PR arms to report having seen their partners, having talked to their partners about the infection, having given the intervention to their partners, and having been told by their partners that the antibiotic treatment had been taken (55.8%, 45.6%, and 35.0%, respectively; P < .001). Of men who were reinterviewed, 37.5% agreed to follow-up testing for N. gonorrhoeae and C. trachomatis infection. Those tested were similar to those not tested with regard to the study variables measured. Among those tested, men in the PDPT and BEPR arms were less likely than those in the PR arm to test positive for C. trachomatis and/or N. gonorrhoeae (23.0%, 14.3%, and 42.7%, respectively; P < .001). Conclusion. Among heterosexual men with urethritis, PDPT was better than standard partner referral for treatment of partners and prevention of recurrence of C. trachomatis or N. gonorrhoeae infection.Keywords
This publication has 16 references indexed in Scilit:
- Effect of Expedited Treatment of Sex Partners on Recurrent or Persistent Gonorrhea or Chlamydial InfectionNew England Journal of Medicine, 2005
- Patient-Delivered Partner Therapy for Sexually Transmitted Diseases as Practiced by U.S. PhysiciansSexually Transmitted Diseases, 2005
- The Legal Status of Patient-Delivered Partner Therapy for Sexually Transmitted Infections in the United StatesSexually Transmitted Diseases, 2005
- Partner Notification for HIV and STD in the United States:Sexually Transmitted Diseases, 2003
- National survey of doctors' actions following the diagnosis of a bacterial STDSexually Transmitted Infections, 2003
- Patient-Delivered Partner Treatment With Azithromycin to Prevent Repeated Chlamydia trachomatis Infection Among WomenSexually Transmitted Diseases, 2003
- Efficacy of Patient-Delivered Partner Medication in the Treatment of Sexual Partners in UgandaSexually Transmitted Diseases, 2001
- Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis.Sexually Transmitted Infections, 1998
- Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis casesJournal of Adolescent Health, 1996
- Contact Tracing in the Control of Genital Chlamydia Trachomatis InfectionInternational Journal of STD & AIDS, 1991